Skip to main content
Caplight Logo









Dynamk Capital

Dynamk Capital

New York City, New Yorkdynamk.vc

Overview

Dynamk Capital is a venture capital firm that invests in early-stage (Seed through Series B) companies developing innovative tools, technologies, and services for the Life Sciences industry. The firm focuses on the underlying technologies that are critical for the discovery, development, and manufacturing of biotherapeutics.

Portfolio Companies

10

Website

dynamk.vc

Investments

Dynamk Capital investments
CompanyDateStageLead
RoosterBioSep 2019Series BLead
Vectron BiosolutionsJun 2021Series ALead
Alpenglow BiosciencesAug 2024VC RoundLead
Lucid ScientificSep 2023Series ACo-investor
Curi BioDec 2021Series ALead
Book a demo to see all 10 portfolio companies

For institutional investors. Book with your work email.

Key People

Mario M. Kranjac

Founding Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Dynamk Capital based?

Dynamk Capital is headquartered in New York City, New York, United States.

When was Dynamk Capital founded?

Founding year information for Dynamk Capital is not publicly available.

How many portfolio companies does Dynamk Capital have?

Dynamk Capital has 10 portfolio companies in Caplight's dataset.

What are some companies in Dynamk Capital's portfolio?

Portfolio companies visible on Caplight include RoosterBio, Vectron Biosolutions, Alpenglow Biosciences, Lucid Scientific, Curi Bio.

What was Dynamk Capital's most recent investment shown here?

Dynamk Capital's most recent investment in this portfolio sample was in Alpenglow Biosciences in 2024.

What sectors does Dynamk Capital focus on?

Dynamk Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does Dynamk Capital focus on?

Dynamk Capital typically invests at the Early stage.

What is Dynamk Capital's AUM?

Dynamk Capital's assets under management are estimated between $65.0M and $65.0M.

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?